Inogen (INGN) Non-Current Deffered Revenue (2013 - 2026)
Inogen (INGN) posted quarterly Non-Current Deffered Revenue of $3.2 million for Q1 2026, down 37.93% year-over-year from $5.1 million in Q1 2025, and down 12.02% quarter-over-quarter from $3.6 million in Q4 2025.
Inogen (INGN) Non-Current Deffered Revenue (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported Non-Current Deffered Revenue for 14 consecutive years, with $3.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Deffered Revenue fell 37.93% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (down 37.93% YoY), while the FY2025 annual figure was $3.6 million, down 37.31% from the prior year.
- Non-Current Deffered Revenue eased to $3.2 million in Q1 2026 per INGN's latest filing, from $3.6 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $11.5 million in Q1 2022 and bottomed at $3.2 million in Q1 2026.
- Historically, Non-Current Deffered Revenue has averaged $7.5 million across 5 years, with a median of $7.6 million in 2024.
- Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue fell 2.81% — and 2026, when it slumped 37.93%.
- Inogen's Non-Current Deffered Revenue stood at $10.4 million in 2022, then slipped by 20.89% to $8.2 million in 2023, then plunged by 30.14% to $5.7 million in 2024, then slumped by 37.31% to $3.6 million in 2025, then declined by 12.02% to $3.2 million in 2026.
- Business Quant data shows INGN's Non-Current Deffered Revenue at $3.2 million in Q1 2026, $3.6 million in Q4 2025, and $4.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Inogen | 152.26 Mn | 46.72 Mn | 43.27 Mn | 2.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.86 Mn |
| Mar 31, 2026 | 3.17 Mn |
| Dec 31, 2025 | 3.60 Mn |
| Sep 30, 2025 | 4.08 Mn |
| Jun 30, 2025 | 4.59 Mn |
| Mar 31, 2025 | 5.11 Mn |
| Dec 31, 2024 | 5.75 Mn |
| Sep 30, 2024 | 6.44 Mn |
| Jun 30, 2024 | 7.07 Mn |
| Mar 31, 2024 | 7.61 Mn |
| Dec 31, 2023 | 8.23 Mn |
| Sep 30, 2023 | 8.88 Mn |
| Jun 30, 2023 | 9.35 Mn |
| Mar 31, 2023 | 9.80 Mn |
| Dec 31, 2022 | 10.40 Mn |
| Sep 30, 2022 | 11.03 Mn |
| Jun 30, 2022 | 11.40 Mn |
| Mar 31, 2022 | 11.51 Mn |
| Dec 31, 2021 | 11.86 Mn |
| Sep 30, 2021 | 12.14 Mn |